MELISSA COMBS: Open Payments
NPI 1245885276 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 25 payments from 16 companies in 2025. Trend: 2023 $415 · 2024 $844 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $112 |
| SANOFI-AVENTIS U.S. LLC | 4 | $78 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 1 | $52 |
| Astellas Pharma US Inc | 2 | $35 |
| Medtronic, Inc. | 2 | $30 |
| Corcept Therapeutics | 1 | $26 |
| CSL Behring | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
Products named: Zilbrysq, TZIELD, GVOKE HYPOPEN, PONVORY, Veozah, Rystiggo, MINIMED 780G, Korlym.
Industry payments across GA — which companies pay providers there.
